Thyroid Gland Hurthle Cell Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09078Lenvatinib2Completed1
DB09037Pembrolizumab2Completed1